- Home
- ASM vs AUTL Comparison
ASM vs AUTL Comparison
Compare ASM & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASM
- AUTL
- Stock Information
- Founded
- ASM 1968
- AUTL 2014
- Country
- ASM Canada
- AUTL United Kingdom
- Employees
- ASM N/A
- AUTL N/A
- Industry
- ASM Metal Mining
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASM Basic Materials
- AUTL Health Care
- Exchange
- ASM Nasdaq
- AUTL Nasdaq
- Market Cap
- ASM 430.0M
- AUTL 359.3M
- IPO Year
- ASM N/A
- AUTL 2018
- Fundamental
- Price
- ASM $3.17
- AUTL $1.75
- Analyst Decision
- ASM Strong Buy
- AUTL Strong Buy
- Analyst Count
- ASM 2
- AUTL 5
- Target Price
- ASM $2.30
- AUTL $9.32
- AVG Volume (30 Days)
- ASM 4.4M
- AUTL 2.4M
- Earning Date
- ASM 05-13-2025
- AUTL 05-08-2025
- Dividend Yield
- ASM N/A
- AUTL N/A
- EPS Growth
- ASM 715.13
- AUTL N/A
- EPS
- ASM 0.10
- AUTL N/A
- Revenue
- ASM $72,621,000.00
- AUTL $9,011,000.00
- Revenue This Year
- ASM $22.93
- AUTL $329.53
- Revenue Next Year
- ASM $25.22
- AUTL $191.73
- P/E Ratio
- ASM $34.81
- AUTL N/A
- Revenue Growth
- ASM 56.32
- AUTL N/A
- 52 Week Low
- ASM $0.83
- AUTL $1.11
- 52 Week High
- ASM $3.30
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- ASM 73.63
- AUTL 66.44
- Support Level
- ASM $2.98
- AUTL $1.19
- Resistance Level
- ASM $3.29
- AUTL $1.79
- Average True Range (ATR)
- ASM 0.20
- AUTL 0.11
- MACD
- ASM 0.03
- AUTL 0.05
- Stochastic Oscillator
- ASM 89.09
- AUTL 93.39
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.